HOUSE-BILL 6509: H.R.6509 - SAFE Drugs Act of 2025
AI-Powered Summary
HOUSE-BILL 6509 aims to regulate compounded drugs to ensure their safety and efficacy for patients who rely on them for health needs. The legislation addresses major themes of public health, patient rights, and pharmacy regulation, emphasizing the need for compounded drugs to be distinct from commercially available products. Key provisions include strict definitions of compounded drugs, limitations on pharmacies regarding the compounding of copies of existing medications, and enhanced oversight for large-scale outsourcing facilities, which may lead to increased reporting requirements for pharmacies serving out-of-state patients. The implementation of these regulations may lead to a more rigorous inspection process and could affect the availability of certain medications for individuals with unique health needs. While the bill seeks to promote public health and safety, there are potential implications for individual rights, particularly concerning access to necessary medical treatments and due process in the enforcement of these regulations.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill's provisions may create barriers to accessing compounded medications, which are crucial for individuals with unique health needs. This could lead to significant disparities in healthcare access, particularly for vulnerable demographic groups.
Key Individual Rights Affected
- Right to Health Care
- Due Process
- Equal Protection
Constitutional Provisions
- Fourteenth Amendment (Equal Protection Clause)
- Fifth Amendment (Due Process Clause)
Potential Constitutional Challenges
- Access to Medications: The restrictions may limit access to essential medications, potentially violating the right to health care.
- Discrimination: If the regulations disproportionately impact certain demographic groups, it could raise equal protection issues.
- Due Process: Reporting requirements may lead to delays in medication access, infringing on individuals' rights.
Summary
HOUSE-BILL 6509 seeks to enhance the regulation of compounded medications, but it raises significant constitutional concerns regarding access to healthcare, due process, and equal protection. The bill's impact on vulnerable populations, such as infants, seniors, and individuals with disabilities, necessitates careful consideration to ensure that individual rights are not unduly compromised.
Constitutional Analysis
This bill has been analyzed for constitutional compliance using AI-powered analysis of constitutional principles and precedents.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention H.R. 6509 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
December 9, 2025
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat